NGL FINECHEM
Back to Income Statement
|
NGL FINECHEM Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹339 Cr | ₹278 Cr | ₹318 Cr | ₹258 Cr | ₹15,168,639 Cr |
What is the latest Revenue of NGL FINECHEM ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹339 Cr |
| Mar2024 | ₹278 Cr |
| Mar2023 | ₹318 Cr |
| Mar2022 | ₹258 Cr |
| Mar2021 | ₹15,168,639 Cr |
How is Revenue of NGL FINECHEM Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹339 Cr | 21.79 | |
| Mar2024 | ₹278 Cr | -12.42 | |
| Mar2023 | ₹318 Cr | 23.08 | |
| Mar2022 | ₹258 Cr | -100.00 | |
| Mar2021 | ₹15,168,639 Cr | - | |
Compare Revenue of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,993.1 Cr | -1.4% | 5% | 135.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹474,396.0 Cr | 1.8% | 5.6% | 16.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,990.0 Cr | 0.5% | 13.1% | 10.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,354.0 Cr | -2.7% | 5.1% | 42.4% | Stock Analytics | |
| CIPLA | ₹116,705.0 Cr | 2.1% | -0.6% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹94,790.0 Cr | -4% | -17.5% | -8.6% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | -1.4% |
5% |
135.5% |
| SENSEX | -0.9% |
-0.4% |
-6.1% |
You may also like the below Video Courses